Multibic

Sodium hydrogen carbonate, magnesium chloride hexahydrate, sodium chloride and calcium chloride dihydrate, the active ingredients in Multibic, are an electrolyte solution presented as a solution for intravenous use for haemodialysis and intravenous administration. It provides essential electrolytes and buffering capacity for patients with renal failure requiring haemodialysis and for electrolyte replacement during intravenous therapy.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide.

Multibic is an electrolyte solution used in renal replacement therapy and intravenous fluid management. - Renal failure requiring haemodialysis: restores electrolyte balance and acid‑base status during dialysis sessions. - Intravenous electrolyte replacement: supplies sodium, chloride, calcium, magnesium and bicarbonate to correct deficits. - Acute kidney injury with need for renal replacement: supports fluid and electrolyte homeostasis while renal function recovers.

Multibic may be associated with electrolyte‑related reactions and infusion‑site responses.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Hyperchloremia: increased chloride concentration. - Hypercalcemia: excess calcium in blood. - Hypermagnesemia: raised magnesium levels. - Infusion site irritation: redness or discomfort at catheter site. - Fluid overload: signs of volume excess such as edema.

Serious or Rare Side Effects: - Severe electrolyte imbalance leading to cardiac arrhythmia. - Anaphylactic or severe hypersensitivity reaction. - Metabolic alkalosis from excess bicarbonate. - Severe hypotension during rapid infusion. - Pulmonary edema due to fluid overload. - Acute kidney injury exacerbation if improperly managed.

When using Multibic, clinicians should observe several safety measures. - Monitor serum electrolytes: check sodium, chloride, calcium, magnesium and bicarbonate levels regularly. - Adjust infusion rate in patients with cardiac disease or fluid‑overload risk. - Use aseptic technique: ensure sterile handling of the solution and infusion set. - Avoid in patients with known hypersensitivity to any component of the formulation. - Use caution in patients with severe liver disease or metabolic disorders. - Store below 25°C: keep in original container, protect from light and moisture.

Multibic can interact with other medications that affect electrolyte balance or acid‑base status.

Major Interactions (Avoid): - Concurrent high‑dose calcium‑containing solutions: may precipitate hypercalcemia. - Additional sodium bicarbonate infusions: risk of metabolic alkalosis. - Potassium‑sparing diuretics combined with high potassium intake: potential hyperkalemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: may require electrolyte monitoring to avoid depletion. - ACE inhibitors or ARBs: watch for additive effects on potassium and renal function. - Anticoagulants used during dialysis: monitor for bleeding if fluid shifts affect hemodynamics.